Medi-post obtains patent for technology that cures Alzheimer's dementia

[DISCLOSURE] Medi-post (078160) said on Aug. 31 that it has acquired a Canadian patent for a technology that cures Alzheimer’s dementia, Parkinson‘s disease and mild cognitive impairment.

The technology uses ICAM-1, a type of protein that removes infected cells.

By Park Yuna ()